The Illinois WOPR Act: A Compliance Reference for Behavioral Health Operators

Overview

On August 1, 2025, Illinois Governor JB Pritzker signed House Bill 1806 into law as the Wellness and Oversight for Psychological Resources Act, becoming Public Act 104-0054. The Act took effect immediately on the date of signing, making Illinois the first state in the United States to enact comprehensive restrictions on the use of artificial intelligence in therapeutic and psychotherapeutic services.

The WOPR Act is structurally narrower than broader AI regulations such as the Illinois Human Rights Act amendments under HB 3773 or the EU AI Act, but it has three features that make it operationally significant for any organization providing or facilitating mental health services in Illinois: it draws a bright line between permitted and prohibited AI uses in clinical workflows, it creates enforcement risk for telehealth and AI mental health platforms based outside Illinois, and it prohibits marketing AI products as therapeutic without a licensed professional in the loop.

The Illinois Department of Financial and Professional Regulation (IDFPR) enforces the Act with civil penalties up to $10,000 per violation. Licensed clinical practitioners face additional licensure consequences for noncompliance, including potential suspension or revocation by the relevant IDFPR licensing board.

Who the law applies to

The WOPR Act applies broadly. Three categories of entities and individuals are within scope:

1. Licensed mental health professionals practicing in Illinois

Clinical psychologists, licensed clinical social workers, licensed clinical professional counselors, marriage and family therapists, psychiatrists, and other licensed practitioners are subject to the Act's restrictions on AI use in clinical workflows. The Act does not prohibit AI use entirely; it sets boundaries around the kinds of AI use that are compatible with the licensed professional standard of care.

2. Healthcare organizations and behavioral health operators

Hospital systems, behavioral health practices, telehealth providers, and any organization that employs or contracts with mental health professionals to provide services in Illinois falls within scope. Organizations are responsible for ensuring that the AI tools used by their clinicians comply with the Act.

3. AI platforms offering services to Illinois users

This is the most expansive category. Any AI platform that offers therapy, psychotherapy, or therapeutic services to users in Illinois is subject to the Act, regardless of the platform's location. A direct-to-consumer AI mental health app based in Delaware with users in Illinois is subject to the WOPR Act for those Illinois users. Platforms must either operate within the Act's permitted use framework, including licensed-professional supervision, or they must refrain from offering services to Illinois users.

Permitted uses of AI

The WOPR Act takes a permissive stance toward AI use that supports licensed professionals without substituting for them. Permitted uses include:

• Practice management. Scheduling, billing, intake forms, eligibility verification, and other administrative workflows that do not involve clinical decision-making.
• Documentation support. AI-assisted note-taking, session summaries, and progress note drafting, provided that the licensed professional reviews and approves all clinical documentation before it is finalized.
• Decision support. AI tools that surface relevant research, clinical guidelines, or differential considerations to the licensed professional, provided that the professional remains the decision-maker and that AI suggestions are not presented to the client as authoritative.
• Quality assurance. Back-office review of session recordings or transcripts for training, supervision, or quality improvement purposes, provided the AI output is not used to make clinical decisions about specific clients.
• Wellness and self-help applications. AI tools offered as wellness support, journaling assistance, mindfulness coaching, or general mental health education, provided they are not marketed or offered as therapy or psychotherapy.

The line between permitted decision support and prohibited independent therapy is the most important line under the Act. The licensed professional must be the decision-maker and must review AI output before it influences a clinical decision or reaches the client.

Prohibited uses of AI

The Act prohibits four categories of AI use in clinical mental health contexts in Illinois:

1. AI as an independent therapist

No AI system may make independent therapeutic decisions, deliver therapy or psychotherapy directly to clients, or substitute for a licensed professional in the therapeutic relationship. An AI chatbot that engages in extended therapeutic conversation with a client, offers diagnostic interpretations, or makes treatment recommendations without licensed professional review is prohibited.

2. AI-generated treatment plans without professional review

AI may not generate treatment plans, treatment goals, or therapeutic interventions that are presented to or used with clients without licensed professional review and approval. Treatment plans drafted by AI must be reviewed, modified as appropriate, and approved by a licensed professional before being implemented.

3. Direct AI-client therapeutic communication

AI systems may not engage clients in therapeutic communication independently. The line between therapeutic communication and other forms of AI-client interaction (scheduling, intake, wellness education) is contextual; operators should err on the side of licensed-professional involvement when communication touches diagnosis, treatment, or therapeutic relationship.

4. Emotion detection in clinical settings

Emotion detection AI — systems that infer emotional states from voice, facial expression, biometrics, or text — is prohibited in clinical-facing contexts where the output could influence therapeutic decisions or be presented to the client. The Act and its implementing guidance specifically target the use of emotion detection as a substitute for clinical assessment.

Restrictions on advertising

The WOPR Act prohibits offering or advertising therapy or psychotherapy services to the public in Illinois unless those services are conducted by a licensed professional. The advertising restriction is independent of the underlying conduct: marketing language alone can create exposure.

Specific marketing claims that create direct WOPR Act exposure include:

• "AI therapist" or "your AI therapist"
• "AI therapy" or "AI-powered therapy"
• "Therapeutic AI"
• "Talk to our AI for emotional support like a therapist"
• Marketing that draws explicit equivalence between AI interactions and human therapy

Compliant marketing alternatives describe AI products accurately using non-clinical language: AI companion, AI coach, wellness support, journaling assistant, mindfulness tool, mental health education, self-help support. These framings allow AI products to operate in Illinois without misrepresenting their function as therapy.

Consent requirements

Where AI is used in permitted ways within a licensed professional relationship, the Act requires informed consent that discloses the AI involvement. Clients must be informed:

• That AI tools are being used in their care
• What the AI is doing (e.g., note-taking, decision support, documentation)
• That a licensed professional remains the decision-maker
• How any data the AI processes is handled, stored, and protected

Existing informed consent forms used by Illinois behavioral health operators should be updated to include AI-specific disclosures. Generic technology consents do not satisfy the Act's specificity requirements.

Penalties and enforcement

The Illinois Department of Financial and Professional Regulation enforces the Act with civil penalties up to $10,000 per violation. Multiple violations — for example, multiple unauthorized therapeutic interactions, multiple deceptive advertising instances, or systemic failures of consent — can compound, with each instance treated as a separate violation.

For licensed practitioners, IDFPR enforcement extends beyond civil penalties to licensure consequences. The relevant licensing board (psychology, social work, counseling, marriage and family therapy, medicine) may impose discipline including suspension or revocation of license for repeated or serious violations.

For unlicensed individuals or entities offering services to the public in Illinois, the Act establishes a clear basis for civil enforcement and, in some cases, criminal prosecution under existing Illinois consumer protection and unauthorized-practice frameworks.

Comparison to other regulations

The WOPR Act is the first state law of its kind. Comparable frameworks operate in adjacent space but with different scope:

HIPAA

HIPAA governs the privacy and security of protected health information. The WOPR Act governs the substantive use of AI in clinical mental health workflows. The two are complementary, not overlapping. HIPAA compliance does not satisfy WOPR Act compliance.

FDA regulation of clinical decision support software

The FDA regulates certain AI-driven clinical decision support systems as medical devices under the FD&C Act. The WOPR Act adds an Illinois-specific layer: even AI systems that are not regulated by the FDA as medical devices may still violate the WOPR Act if they deliver therapy or psychotherapy independently. FDA clearance of an AI tool does not exempt it from WOPR Act compliance.

EU AI Act

The EU AI Act classifies certain AI in healthcare as "high-risk" and imposes documentation and conformity assessment obligations. The WOPR Act is structurally lighter but more categorical: it prohibits specific uses outright rather than imposing process requirements on them.

Other state mental health AI legislation

As of May 2026, Illinois is the only US state with a statute as explicit as the WOPR Act. Several other states have introduced similar bills; New York's AI Mental Health Services Disclosure Act (in legislative consideration) would impose disclosure requirements without the categorical prohibitions of the WOPR framework. Operators with multi-state presence should monitor parallel developments in California, New York, and Massachusetts.

Compliance steps for behavioral health operators

A defensible WOPR Act compliance posture is documented in five components:

1. Build a clinical AI inventory

Catalog every AI tool used in any clinical-adjacent workflow: therapy session support, intake assessment, documentation, scheduling, decision support, training, billing. For each tool, document the vendor, the function, the workflow integration point, and which licensed professional is responsible for the AI's outputs.

2. Map each tool against the permitted/prohibited categories

For each AI tool in the inventory, determine whether its use falls within the Act's permitted uses (with appropriate licensed-professional oversight) or violates the prohibited uses. Tools whose use is ambiguous warrant a written compliance memo documenting the operator's reasoning.

3. Update consent and disclosure materials

Revise informed consent forms to include AI-specific disclosures that meet the Act's requirements. Update the practice's notice of privacy practices and any client-facing technology disclosures. Train clinical staff on the consent conversation, including addressing client questions about AI use in their care.

4. Conduct vendor due diligence

For each third-party AI tool, require documentation from the vendor on: how the tool is used in clinical workflows, what licensed professional oversight is required, how the tool's output is presented to clinicians and clients, whether emotion detection is used, and how the vendor handles WOPR Act compliance. Vendor representations alone are not a defense; documentation provides a record of reasonable diligence.

5. Document the compliance posture

Produce a compliance memo summarizing the AI inventory, the permitted/prohibited mapping, the consent updates, and the vendor due diligence outcomes. The memo serves IDFPR in the event of an inquiry, supports D&O renewal conversations, and provides the audit committee with a readable summary of compliance posture.

For AI platforms operating in Illinois

Direct-to-consumer AI mental health platforms face a different compliance challenge. The platform itself is the AI; there is no licensed professional in the loop unless one is added. Three compliance pathways exist:

Pathway 1 — Reposition the product

Reframe the platform as wellness support, journaling assistance, mindfulness coaching, or AI companion — categories outside the WOPR Act's clinical scope. This requires substantive product changes (not just marketing changes): the platform must actually function as the repositioned product, not as a therapy substitute with new branding.

Pathway 2 — Add licensed professional oversight

Integrate licensed professionals into the platform's clinical workflow such that all therapeutic interactions, treatment plan generation, and clinical decisions involve a licensed Illinois professional. This is operationally complex and significantly changes the platform's economics, but it allows the platform to operate in the clinical category.

Pathway 3 — Geofence Illinois users

Detect and exclude Illinois-based users from clinical-style interactions, while allowing them access to non-clinical features. This requires reliable user-location detection and a willingness to forgo the Illinois market for the affected use cases.

Each pathway has trade-offs. Operators should make the choice deliberately, with documentation of why the chosen pathway suits the product, and with monitoring for regulatory updates that might expand or narrow the Act's scope over time.

---

This article was last reviewed on May 9, 2026. The WOPR Act is a new statute and IDFPR enforcement patterns are still developing. Operators should monitor IDFPR guidance and the Illinois AI Legislative Ecosystem tracker for updates. For an organization-specific compliance review under the WOPR Act, see the WOPR Act Compliance Review service description.